CA

Calliditas Therapeutics ABSTO Calliditas Therapeutics Stock Report

Last reporting period 30 Jun, 2024

Updated 10 Oct, 2024

Last price

Market cap $B

1.095

Small

Exchange

XSTO - Nasdaq STOCKHOLM AB

View Full Company Analysis

Calliditas Financial Leverage

7.555

Last period Financial Leverage ,SEK

617%

Financial Leverage has increased in 5 years


What is Financial Leverage ?

Financial leverage is a multiplier that shows how much of a company's assets are financed by debts and other liabilities assumed. The higher the value of this indicator, the more often the company resorts to borrowing to purchase new assets.

What is Financial Leverage ?

Financial leverage is a multiplier that shows how much of a company's assets are financed by debts and other liabilities assumed. The higher the value of this indicator, the more often the company resorts to borrowing to purchase new assets.

What is Financial Leverage of Calliditas Therapeutics ?

Calliditas Therapeutics`s Financial Leverage for the last twelve months ended 2024-06-30 is 7.555

View Full Company Analysis